Physician profile
Michael A Matthay
NPI 1891734497
$60,258.49
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,050 · 2020: $9,664 · 2021: $4,900 · 2022: $3,356 · 2023: $8,152 · 2024: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Travel and Lodging: $17K · Food and Beverage: $747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,635.00 |
| Travel and Lodging | $16,906.97 |
| Food and Beverage | $746.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $33,547.46 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $7,741.24 | 2024 | |
| Shionogi INC | $7,000.00 | 2020 | |
| Gilead Sciences, INC. | $5,950.00 | 2021-2022 | |
| Terumo Bct, INC. | $2,664.00 | 2020 | |
| Global Blood Therapeutics, INC. | $2,282.00 | 2022 | |
| Jazz Pharmaceuticals INC. | $1,050.00 | 2019 | |
| Abbott Laboratories | $23.79 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Matthay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.